-
The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021 Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-19
BackgroundHigh-quality estimates of the epidemiology of the autism spectrum and the health needs of autistic people are necessary for service planners and resource allocators. Here we present the global prevalence and health burden of autism spectrum disorder from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 following improvements to the epidemiological data and burden
-
Advancing global mental health diplomacy through a rights-based approach Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-19 Jakub S Bil
No Abstract
-
Global prevalence of autism in changing times Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-19 Tony Charman
No Abstract
-
-
Balancing evidence and interpretation of ADHD treatments Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-17 David Coghill
No Abstract
-
Coercive hospitalisation in China Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-17 Yang Zhang, Xingbo Suo, Jin Gao
No Abstract
-
Maxime Taquet—from engineering to psychiatry Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-17 Tony Kirby
No Abstract
-
Healing through illustration Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-17 Alina Kurokhtina
No Abstract
-
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-17 Edoardo G Ostinelli, Marcel Schulze, Caroline Zangani, Luis C Farhat, Anneka Tomlinson, Cinzia Del Giovane, Samuel R Chamberlain, Alexandra Philipsen, Susan Young, Phil J Cowen, Andrea Bilbow, Andrea Cipriani, Samuele Cortese
BackgroundThe comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps. MethodsIn this systematic review and component network meta-analysis (NMA), we searched multiple databases for published and unpublished randomised controlled trials (RCTs) investigating pharmacological and non-pharmacological interventions for
-
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-18 Venexia M Walker,Praveetha Patalay,Jonathan A C Sterne
-
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19? JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-18 Yaakov Ophir,Yaffa Shir-Raz
-
Youth Generalized Anxiety and Brain Activation States During Socioemotional Processing JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-18 M. Catalina Camacho, Rebecca F. Schwarzlose, Michael T. Perino, Alyssa K. Labonte, Sanju Koirala, Deanna M. Barch, Chad M. Sylvester
ImportanceThe brain enters distinct activation states to support differential cognitive and emotional processes, but little is known about how brain activation states differ in youths with clinical anxiety.ObjectiveTo characterize brain activation states during socioemotional processing (movie stimuli) and assess associations between state characteristics and movie features and anxiety symptoms.Design
-
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-18 Lori L. Davis, Saloni Behl, Daniel Lee, Hui Zeng, Taisa Skubiak, Shelley Weaver, Nanco Hefting, Klaus Groes Larsen, Mary Hobart
ImportanceNew pharmacotherapy options are needed for posttraumatic stress disorder (PTSD).ObjectiveTo investigate the efficacy, safety, and tolerability of brexpiprazole and sertraline combination treatment (brexpiprazole + sertraline) compared with sertraline + placebo for PTSD.Design, Setting, and ParticipantsThis was a parallel-design, double-blind, randomized clinical trial conducted from October
-
Film Review: A Cielo Abierto (Upon Open Sky): A Film of Adolescent Transition J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-12-13 Owen Lewis
-
-
-
Reducing risk when publishing academic articles about suicide Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-10 Lorna Fraser, Jacqui Morrissey, Louis Appleby
No Abstract
-
Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-11 Samuel J Westwood,Pascal-M Aggensteiner,Anna Kaiser,Peter Nagy,Federica Donno,Dóra Merkl,Carla Balia,Allison Goujon,Elisa Bousquet,Agata Maria Capodiferro,Laura Derks,Diane Purper-Ouakil,Sara Carucci,Martin Holtmann,Daniel Brandeis,Samuele Cortese,Edmund J S Sonuga-Barke,
Importance Neurofeedback has been proposed for the treatment of attention-deficit/hyperactivity disorder (ADHD) but the efficacy of this intervention remains unclear. Objective To conduct a meta-analysis of randomized clinical trials (RCTs) using probably blinded (ie, rated by individuals probably or certainly unaware of treatment allocation) or neuropsychological outcomes to test the efficacy of neurofeedback
-
Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-11 Aurina Arnatkeviciute, Alex Fornito, Janette Tong, Ken Pang, Ben D. Fulcher, Mark A. Bellgrove
ImportanceLarge-scale genome-wide association studies (GWAS) should ideally inform the development of pharmacological treatments, but whether GWAS-identified mechanisms of disease liability correspond to the pathophysiological processes targeted by current pharmacological treatments is unclear.ObjectiveTo investigate whether functional information from a range of open bioinformatics datasets can elucidate
-
Private Equity Ownership of US Opioid Treatment Programs. JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-11 David T Zhu,Zirui Song,Sneha Kannan,Christopher L Cai,Simar S Bajaj,Suhas Gondi
-
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-11 Carlos M Grilo,Valentina Ivezaj,Cenk Tek,Sydney Yurkow,Ashley A Wiedemann,Ralitza Gueorguieva
OBJECTIVE Binge-eating disorder (BED) is a prevalent, costly public health problem associated with serious functional impairments and heightened rates of psychiatric and medical comorbidities. Few evidence-based treatments are currently available for BED. We tested the effectiveness of cognitive-behavioral therapy (CBT), lisdexamfetamine (LDX), and combined CBT+LDX, for BED comorbid with obesity. METHODS
-
Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-11 George Kypriotakis,Paul M Cinciripini,Charles E Green,David Lawrence,Robert M Anthenelli,Jennifer A Minnix,Diane Beneventi,Chad Morris,Maher Karam-Hage,Janice A Blalock
OBJECTIVE The aim of this study was to compare the safety and efficacy of the leading smoking cessation medications among individuals with current versus past major depressive disorder (MDD). METHODS This was a secondary analysis of a randomized, double-blind trial over 12 weeks with varenicline or bupropion, followed by a 12-week assessment, in participants ages 18-75 with past (N=2,174) or current
-
Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-11 Matthias Brand,Stephanie Antons,Beata Bőthe,Zsolt Demetrovics,Naomi A Fineberg,Susana Jimenez-Murcia,Daniel L King,Gemma Mestre-Bach,Tania Moretta,Astrid Müller,Elisa Wegmann,Marc N Potenza
Gambling disorder is the only behavioral addiction recognized as a clinical disorder in DSM-5, and Internet gaming disorder is included as a condition requiring further research. ICD-11 categorizes gambling and gaming disorders as disorders due to addictive behaviors. Additional behavioral addictions may include compulsive sexual behavior disorder, compulsive buying-shopping disorder, and problematic
-
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-11 William P Horan,Colin Sauder,Philip D Harvey,Ian S Ramsay,Samantha E Yohn,Richard S E Keefe,Vicki G Davis,Steven M Paul,Stephen K Brannan
OBJECTIVE Xanomeline and trospium chloride (formerly known as KarXT), a novel M1/M4 muscarinic receptor agonist, demonstrated efficacy across phase 2 and 3 trials as monotherapy for the treatment of inpatients with acute schizophrenia on the Positive and Negative Syndrome Scale total score primary endpoint. In the phase 2 trial, xanomeline/trospium improved performance on a cognitive outcome measure
-
-
Introduction: Martha Southgate Essay J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-12-11 Kerry L. Malawista
-
Treatment Expectancies and Psilocybin vs Escitalopram for Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-10 Ethan G. Dutcher, Andrew D. Krystal
This randomized controlled trial secondary analysis examines the association between treatment expectancies and the relative efficacy of psilocybin compared with escitalopram for major depressive disorder.
-
Quality of reporting on psychological interventions in psychedelic treatments: a systematic review Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-09 Carolina Seybert, Nina Schimmers, Lucio Silva, Joost J Breeksema, Jolien Veraart, Bárbara S Bessa, Dora d'Orsi, Robert A Schoevers, Albino J Oliveira-Maia
Although studies of psychedelic-assisted psychotherapy are accumulating, there is no consensus regarding best practice of the psychotherapeutic component. In this systematic review, we summarised the quality of reporting on psychological interventions in research about psychedelic treatments. The design followed PRISMA guidelines and was preregistered in PROSPERO (CRD42022319221). We searched MEDLINE
-
What I’m Reading Now: Shakespeare’s Twelfth Night and Old-Old Age J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-12-09 Warren S. Poland
-
Nuanced epidemiology for nuanced care: addressing the substantial mental health needs of adolescents Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-04 Karolin Rose Krause, Peter Szatmari
No Abstract
-
Correction to Lancet Psychiatry 2024; published online Nov 21. https://doi.org/10.1016/S2215-0366(24)00365-1 Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-04
Zavlis O, Luyten P, Pilling S, Fonagy P. Pressing need for clinical trial research on dimensional personality disorder. Lancet Psychiatry 2024; published online Nov 21. https://doi.org/10.1016/s2215-0366(24)00365-1. In this Correspondence, the second sentence of the first paragraph should read, “However, national health guidelines (such as those from the UK's National Institute of Clinical Excellence)
-
Tracking the course of depressive and anxiety symptoms across adolescence (the CATS study): a population-based cohort study in Australia Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-04 Ellie May Robson, Hanafi M Husin, Seydeh Ghazaleh Dashti, Nandita Vijayakumar, Margarita Moreno-Betancur, Paul Moran, George C Patton, Susan M Sawyer
BackgroundAdolescent mental health appears to be in crisis, yet few studies have comprehensively charted the course of common mental disorders (CMDs; depression and anxiety) across this key life stage. We aimed to describe the course of CMD symptoms in adolescence by summarising annual prevalence, cumulative incidence, and course for depression and anxiety, both separately and as comorbid CMDs, by
-
Psychological Interventions for Pediatric Posttraumatic Stress Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-04 Thole H. Hoppen, Lena Wessarges, Marvin Jehn, Julian Mutz, Ahlke Kip, Pascal Schlechter, Richard Meiser-Stedman, Nexhmedin Morina
ImportancePediatric posttraumatic stress disorder (PTSD) is a common and debilitating mental disorder, yet a comprehensive network meta-analysis examining psychological interventions is lacking.ObjectiveTo synthesize all available evidence on psychological interventions for pediatric PTSD in a comprehensive systematic review and network meta-analysis.Data SourcesPsycINFO, MEDLINE, Web of Science, and
-
Trends in Outpatient Psychotherapy Among Adults in the US JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-04 Mark Olfson, Chandler McClellan, Samuel H. Zuvekas, Melanie Wall, Carlos Blanco
ImportanceWhile access to psychotherapy has recently increased in the US, concern exists that recent gains may be unevenly distributed despite teletherapy expansion.ObjectiveTo characterize recent trends and patterns in outpatient psychotherapy by US adults.Design, Setting, and ParticipantsThis is a repeated cross-sectional study of psychotherapy use among adults (ages ≥18 years) in the 2018 to 2021
-
Capturing the Full Range of Buprenorphine Treatment Response JAMA Psychiatry (IF 22.5) Pub Date : 2024-12-04 Allen J. Bailey, Victoria R. Votaw, Roger D. Weiss, R. Kathryn McHugh
ImportanceReliance on abstinence-based treatment success rules may fail to capture the full continuum of treatment response to buprenorphine plus medical counseling (BUP+MC) for opioid use disorder (OUD).ObjectiveTo describe patterns of reduction in illicit opioid use of patients both labeled as a success and nonsuccess based on an abstinent-based treatment outcome rule.Design, Setting, and ParticipantsThis
-
Decriminalising attempted suicide in Nigeria Lancet Psychiatry (IF 30.8) Pub Date : 2024-12-02 Adegboyega Ogunwale, Tunde Masseyferguson Ojo
No Abstract
-
The Importance and Limitations of Null Findings. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Dan J Stein,Jack van Honk,Paul M Thompson
-
Pathways to Homelessness: Childhood Maltreatment and Psychiatric Symptoms Increase Risk of Homelessness. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Cathy Spatz Widom,Kellie Courtney,Hang Heather Do
OBJECTIVE Homelessness is a serious and increasing public health concern. Childhood maltreatment and psychiatric problems have been associated with homelessness as risk factors; however, reliance on cross-sectional studies introduces ambiguity into interpreting previous findings. This study seeks to understand whether psychiatric symptoms in part explain the relationship between childhood maltreatment
-
Centering Agency and Choice in Moving Toward Social Justice in Mental Health: Reflections on Childhood Maltreatment, Psychiatric Symptoms, and Homelessness. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Ana Carolina Florence,Ezra Susser
-
An Honest Reckoning With the Amygdala and Mental Illness. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Andrew S Fox,Alexander J Shackman
Anxiety disorders are a leading source of human misery, morbidity, and premature mortality. Existing treatments are far from curative for many, underscoring the need to clarify the underlying neural mechanisms. Although many brain regions contribute, the amygdala has received the most intense scientific attention. Over the past several decades, this scrutiny has yielded a detailed understanding of
-
Charting the Neural Pathways From Discrimination to Mental Health Disparities. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Erika E Forbes
-
Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Lauren M Sippel,Jessica L Hamblen,Benjamin Kelmendi,Jonathan E Alpert,Linda L Carpenter,Adrienne Grzenda,Nina Kraguljac,William M McDonald,Carolyn I Rodriguez,Alik S Widge,Charles B Nemeroff,Paula P Schnurr,Paul E Holtzheimer,
Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. The most commonly recommended first-line treatments for PTSD among adults are individual trauma-focused psychotherapies. Other evidence-based treatments include specific antidepressant medications and non-trauma-focused psychotherapies. Despite the effectiveness
-
Homelessness, Discrimination, PTSD, Autism, and the Amygdala. Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Ned H Kalin
-
With Apologies to Monty Python: Is Every Cell Sacred? Am. J. Psychiatry (IF 15.1) Pub Date : 2024-12-01 Michaela E Price,Zoé A McElligott
-
Bodily Distress and International Classification of Diseases-11: Advances, Loose Ends, and Some Confusion. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-29 Peter Henningsen,Bernd Löwe
-
Film Essay: Trauma and Dissociation in Drive My Car J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-29 Judith A. Yanof
-
Hidden Costs: The Clinical and Research Pitfalls of Mistaking Antidepressant Withdrawal for Relapse. Psychother. Psychosom. (IF 16.3) Pub Date : 2024-11-28 Mark A Horowitz,James Davies
-
Lessons in Masculinity: Howard Stern and Bruce Springsteen On How Psychoanalysis Changed their Lives J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-28 Madelon Sprengnether
-
Characteristics of Adults Treated at Mental Health Treatment Centers in the US, 2022 JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-27 Susan H. Busch, Jason Hockenberry, Helen Newton
This cross-sectional study examines demographic characteristics of adults treated at outpatient mental health treatment centers using data from the 2022 US National Survey of Drug Use and Health.
-
Mental Health Disorder Trends in Denmark According to Age, Calendar Period, and Birth Cohort JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-27 Natalie C. Momen, Christoffer Beck, Mette Lise Lousdal, Esben Agerbo, John J. McGrath, Carsten B. Pedersen, Merete Nordentoft, Oleguer Plana-Ripoll
ImportanceResearch suggests an increase in mental disorder incidence in recent years, but this trend remains unexplained, and there is a lack of large studies based on a representative sample that investigate mental disorders over the full spectrum.ObjectiveTo explore sex- and age-specific incidence of any mental disorder and 19 specific disorders according to birth cohort and calendar period.Design
-
A Framework for Suicide Risk Screening After Overdose JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-27 Matthew Robert Dernbach, Randi N. Smith, Joseph E. Carpenter
This Viewpoint proposes applying a systematic curriculum for early management of traumatically injured patients as a framework for suicide risk screening after overdose.
-
Book Review: Transference, Love, Being: Essential Essays From the Field J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-27 Salman Akhtar
-
Why I Write: From the Rags of Time J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-27 Nilofer Kaul
-
What I’m Reading Now: The Front Table J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-27 Elizabeth Hamlin
-
Misrepresentation by online study participants—a threat to data integrity Lancet Psychiatry (IF 30.8) Pub Date : 2024-11-25 Blandine French, Camilla Babbage, Sarah Cassidy, Stefan Rennick-Egglestone
No Abstract
-
Putting opacity back into outcome Lancet Psychiatry (IF 30.8) Pub Date : 2024-11-26 Christiane Steinert
No Abstract
-
Client-identified outcomes of individual psychotherapy: a qualitative meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-11-26 Michaela Ladmanová, Tomáš Řiháček, Ladislav Timulak, Klára Jonášová, Barbora Kubantová, Petr Mikoška, Lucia Polakovská, Robert Elliott
BackgroundPsychotherapy outcomes are typically measured in terms of symptom relief. However, this method might overlook important changes from clients' perspectives when they are asked to report on them. A more client-centred approach might bring a deeper understanding of psychotherapy outcomes. We aimed to evaluate the outcomes identified by clients within qualitative psychotherapy research. MethodsThe
-
Writing as Thinking and Loving J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-23 Andrea Celenza
-
Book Review: Psychoanalysis, the Self, and the World: Postphenomenology, Consciousness, and Death J. Am. Psychoanal. Assoc. (IF 1.4) Pub Date : 2024-11-23 Jeffrey McCurry
-
Pressing need for clinical trial research on dimensional personality disorder Lancet Psychiatry (IF 30.8) Pub Date : 2024-11-21 Orestis Zavlis, Patrick Luyten, Steve Pilling, Peter Fonagy
No Abstract